Open original FDA record ↗Recall record
- FDA identifier
- Z-1477-2017
- Company in FDA record
- C2 Therapeutics, Inc.
- FDA classification date
- Mar 15, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Controller Cap of the C2 CyroBalloon Ablation System may crack as it is tightened onto the controller. That could compromise the integrity and result in damage to the Controller Cap.
Source facts
- Action
- Firm initially notified consignees who would be using the device in an upcoming procedure on January 6, 2017 to alert them of the potential issue and recommended that products with the affected cap not be used unless it can be checked by a C2 rep. Controller caps will be replaced within a few weeks; facilities will receive replacement caps by mail along with a shipping inventory label for return of those currently on hand. Formal recall letters were sent on January 19, 2017. Letters were sent by e-mail with receipt and read confirmation and follow up by phone call.
- Initiated
- 2017-01-06
- Root cause
- Under Investigation by firm
- Terminated
- 2017-09-13
- Distribution
- Worldwide Distribution - US Nationwide and the countries of Germany, Belgium, The Netherlands United Kingdom and China.
- Recall number
- Z-1477-2017
- Recall status
- Terminated
- CDRH record ID
- 152962
- FDA classified
- 2017-03-15
- Recall event number
- 76358